Vanguard Global Advisers »

Polaryx Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Polaryx Therapeutics shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Polaryx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Polaryx Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Polaryx Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $48k 6.3k 7.56

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Polaryx Therapeutics

Vanguard Capital Management
Geode Capital Management
Millennium Management
Vanguard Fiduciary Trust
BlackRock
Bank of America Corporation
Goldman Sachs Group
UBS Group
Squarepoint Ops
Vanguard Global Advisers
Morgan Stanley

View all funds holding Polaryx Therapeutics